Valneva SE
PAR:VLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valneva SE
PAR:VLA
|
FR |
|
F
|
Fluor Corp
DUS:FLU
|
US |
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
A
|
A2A SpA
F:EAM
|
IT |
|
B
|
Blu Label Unlimited Group Ltd
JSE:BLU
|
ZA |
|
A
|
AES Corp
XMUN:AES
|
US |
|
O
|
Oriental Land Co Ltd
OTC:OLCLY
|
JP |
Intrinsic Value
Is VLA undervalued or overvalued?
See the intrinsic value estimate for Valneva SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Valneva Does
Valneva is a vaccine company. It develops, makes, and sells vaccines that help prevent infectious diseases, with a focus on travel and other niche areas where public health agencies and doctors need specific protection rather than broad everyday medicines. Its best-known products include vaccines for diseases such as Japanese encephalitis, cholera, and other travel-related infections, along with vaccine candidates still in development.
- Headquarters
- France FR
- Employees
- 674
- IPO date
- Jun 28, 2007
Revenue & Expenses Breakdown
Valneva SE
Earnings Waterfall
Valneva SE
The intrinsic value for Valneva SE (VLA) under the Base Case is hidden EUR.
Compared with the current market price of 2.558 EUR, the stock appears hidden.